Mounjaro has been involved with gastrointestinal adverse reactions, which consist of nausea, vomiting, and diarrhea. These activities may possibly cause dehydration, which if significant could cause acute kidney injuries. In individuals treated with GLP-one receptor agonists, there have been postmarketing reports of acute kidney injuries and worsen